Muscular dystrophy refers to a group of inherited neuromuscular conditions characterised by progressive muscle weakness, loss of muscle mass, and declining physical function. The condition typically presents in childhood or early adulthood, though onset and severity vary widely depending on the specific subtype. Muscular dystrophy is commonly framed as a genetic disorder in which defects in muscle-related proteins lead to irreversible degeneration of skeletal muscle tissue.

‍

This framing has shaped clinical understanding for decades. Muscular dystrophy is often presented as a condition with a predictable trajectory of decline, managed primarily through supportive care aimed at preserving mobility and delaying complications. While genetic mutations play a central role, this perspective leaves important questions unanswered regarding variability in disease progression, functional capacity, and symptom burden among individuals with similar diagnoses.

‍

Despite its classification as a genetic disorder, muscular dystrophy displays considerable heterogeneity. Some individuals experience rapid loss of muscle strength and early disability, while others maintain functional independence for extended periods. Differences in disease course suggest that genetic mutation alone does not fully determine outcome and that additional biological factors influence muscle resilience over time.

‍

At the cellular level, muscle fibres are highly dynamic structures. They undergo continuous cycles of damage and repair in response to mechanical load and metabolic demand. Muscle integrity depends on efficient protein synthesis, mitochondrial energy production, calcium handling, and coordination between muscle cells and their surrounding connective tissue.

‍

In muscular dystrophy, structural proteins that stabilise muscle fibres are compromised, making cells more vulnerable to mechanical stress. Repeated cycles of damage without adequate repair contribute to progressive weakness. However, the rate at which damage accumulates varies, indicating that repair capacity and metabolic support play important modulatory roles.

‍

Energy metabolism is central to muscle function. Skeletal muscle is one of the body’s most energy-demanding tissues, particularly during movement and postural control. Mitochondria within muscle cells supply ATP required for contraction, repair, and maintenance of cellular integrity. Impaired mitochondrial efficiency can therefore accelerate functional decline.

‍

Mitochondrial dysfunction has been observed in several forms of muscular dystrophy. Reduced oxidative capacity, altered substrate utilisation, and increased production of reactive oxygen species may place additional stress on already vulnerable muscle fibres. Over time, cumulative energetic strain may limit the ability of muscle tissue to adapt and recover.

‍

Oxidative stress further contributes to muscle damage. Reactive oxygen species generated during contraction and inflammation can damage proteins, lipids, and DNA. While antioxidant systems normally counterbalance this stress, chronic imbalance may exacerbate muscle degeneration and impair regenerative processes.

‍

Inflammation represents another important dimension of muscular dystrophy. Damaged muscle fibres trigger immune responses aimed at clearing debris and initiating repair. In acute injury, this process is adaptive. In chronic conditions, however, persistent low-grade inflammation may interfere with effective regeneration and promote fibrosis.

‍

Fibrosis, characterised by excessive deposition of connective tissue, reduces muscle elasticity and functional capacity. Once established, fibrotic tissue limits contractile potential and further impairs muscle performance. The extent and timing of fibrosis vary between individuals, contributing to differences in disease severity.

‍

The nervous system also plays a role in muscular dystrophy. Motor neurons, neuromuscular junctions, and muscle fibres function as an integrated unit. Alterations in neural signalling, whether primary or secondary to muscle pathology, may influence muscle activation patterns and functional output.

‍

Respiratory and cardiac muscles are often affected in muscular dystrophy, making systemic consequences a central concern. Weakness of respiratory muscles can impair ventilation and increase susceptibility to infection, while involvement of cardiac muscle may lead to cardiomyopathy and rhythm disturbances.

‍

Fatigue is a common and often underestimated symptom. It reflects not only muscle weakness but also metabolic inefficiency, inflammatory signalling, and increased energy expenditure required for basic movement.

‍

Nutritional status and metabolic health influence muscle resilience. Adequate availability of amino acids, micronutrients, and energy substrates supports protein synthesis and repair.

‍

The gastrointestinal system may indirectly influence muscular dystrophy through immune regulation and nutrient absorption.

‍

Genetic predisposition establishes the framework for muscular dystrophy, but gene expression and functional outcome are shaped by environmental and metabolic context.

‍

One of the most striking aspects of muscular dystrophy is variability in functional adaptation.

‍

The concept of biological resilience provides a useful framework for understanding muscular dystrophy.

‍

Despite extensive research, no single mechanism fully explains muscular dystrophy progression.

‍

These questions are explored in greater depth in the book How to Survive a Modern Lifestyle by David Collins.

‍